Bafna Pharmaceuticals Management
Management criteria checks 2/4
Bafna Pharmaceuticals' CEO is Bansilal Mahaveer Bafna, appointed in Dec 2005, has a tenure of 18.92 years. directly owns 0.2% of the company’s shares, worth ₹3.79M. The average tenure of the management team and the board of directors is 7.5 years and 4 years respectively.
Key information
Bansilal Mahaveer Bafna
Chief executive officer
₹7.5m
Total compensation
CEO salary percentage | n/a |
CEO tenure | 18.9yrs |
CEO ownership | 0.2% |
Management average tenure | 7.5yrs |
Board average tenure | 4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | ₹4m |
Jun 30 2024 | n/a | n/a | ₹3m |
Mar 31 2024 | ₹8m | n/a | ₹73m |
Dec 31 2023 | n/a | n/a | ₹113m |
Sep 30 2023 | n/a | n/a | ₹172m |
Jun 30 2023 | n/a | n/a | ₹163m |
Mar 31 2023 | ₹4m | n/a | ₹113m |
Dec 31 2022 | n/a | n/a | ₹50m |
Sep 30 2022 | n/a | n/a | ₹37m |
Jun 30 2022 | n/a | n/a | ₹44m |
Mar 31 2022 | ₹4m | n/a | ₹52m |
Dec 31 2021 | n/a | n/a | ₹88m |
Sep 30 2021 | n/a | n/a | ₹80m |
Jun 30 2021 | n/a | n/a | ₹61m |
Mar 31 2021 | ₹3m | n/a | ₹58m |
Dec 31 2020 | n/a | n/a | ₹256m |
Sep 30 2020 | n/a | n/a | ₹28m |
Jun 30 2020 | n/a | n/a | ₹18m |
Mar 31 2020 | ₹2m | ₹2m | -₹19m |
Dec 31 2019 | n/a | n/a | -₹394m |
Sep 30 2019 | n/a | n/a | -₹178m |
Jun 30 2019 | n/a | n/a | -₹196m |
Mar 31 2019 | ₹2m | ₹2m | -₹199m |
Mar 31 2018 | ₹2m | ₹2m | -₹167m |
Compensation vs Market: Bansilal Mahaveer's total compensation ($USD89.17K) is above average for companies of similar size in the Indian market ($USD42.72K).
Compensation vs Earnings: Bansilal Mahaveer's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Bansilal Mahaveer Bafna (63 yo)
18.9yrs
Tenure
₹7,518,000
Compensation
Mr. Bansilal Mahaveer Chand Bafna has been Chief Executive Officer of Bafna Pharmaceuticals Limited since September 10, 2020 and served as Chairman and Managing Director of Bafna Pharmaceuticals Limited si...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 18.9yrs | ₹7.52m | 0.20% ₹ 3.8m | |
Chief Financial Officer | 7.5yrs | ₹1.37m | no data | |
Whole-Time Director of Quality | no data | ₹2.21m | no data | |
Executive Chairman | 4.2yrs | no data | no data | |
Company Secretary & Compliance Officer | less than a year | no data | no data |
7.5yrs
Average Tenure
52.5yo
Average Age
Experienced Management: 532989's management team is seasoned and experienced (7.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Whole-Time Director of Quality | 1.4yrs | ₹2.21m | no data | |
Executive Chairman | 4.2yrs | no data | no data | |
Non-Executive & Independent Director | 4.4yrs | ₹121.00k | no data | |
Additional Non-Executive Non-Independent Director | 1.4yrs | ₹55.00k | no data | |
Non-Executive & Independent Director | 4yrs | ₹110.00k | no data | |
Non-Executive & Non-Independent Director | 4.2yrs | ₹88.00k | no data | |
Non-Executive Independent Director | 1.4yrs | ₹22.00k | no data |
4.0yrs
Average Tenure
46yo
Average Age
Experienced Board: 532989's board of directors are considered experienced (4 years average tenure).